Sign In
Buy MMSI
$67.27
+0.770 (+1.16%)
At Close: Jun 23, 2026
Merit Medical Q2 Earnings Beat Estimates, Gross Margin Expands
02:20pm, Thursday, 31'st Jul 2025
MMSI beats second-quarter 2025 earnings estimates as gross margin expands and strong U.S. and Cardiovascular sales drive revenue growth.
Merit Medical Systems, Inc. (MMSI) Q2 2025 Earnings Call Transcript
11:43am, Thursday, 31'st Jul 2025
Merit Medical Systems, Inc. (NASDAQ:MMSI ) Q2 2025 Earnings Conference Call July 30, 2025 5:00 PM ET Company Participants Brian G. Lloyd - Chief Legal Officer & Corporate Secretary Fred P.
Merit Medical (MMSI) Reports Q2 Earnings: What Key Metrics Have to Say
07:31pm, Wednesday, 30'th Jul 2025
While the top- and bottom-line numbers for Merit Medical (MMSI) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics comp
Will Merit Medical (MMSI) Beat Estimates Again in Its Next Earnings Report?
01:11pm, Wednesday, 23'rd Jul 2025
Merit Medical (MMSI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
XRAY vs. MMSI: Which Stock Is the Better Value Option?
12:40pm, Friday, 18'th Jul 2025
Investors interested in Medical - Dental Supplies stocks are likely familiar with Dentsply International (XRAY) and Merit Medical (MMSI). But which of these two companies is the best option for those
Merit Medical Names Martha Aronson as New President and Chief Executive Officer
04:05pm, Monday, 07'th Jul 2025
Fred Lampropoulos will continue to serve as Chairman of Merit's Board of Directors Merit announces preliminary unaudited revenue for the quarter ended June 30, 2025 SOUTH JORDAN, Utah, July 07, 2025 (
Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025
04:05pm, Thursday, 03'rd Jul 2025
SOUTH JORDAN, Utah, July 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will rele
XRAY or MMSI: Which Is the Better Value Stock Right Now?
12:41pm, Wednesday, 02'nd Jul 2025
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Dentsply International (XRAY) and Merit Medical (MMSI). But which of these two stocks offers value investors
XRAY vs. MMSI: Which Stock Is the Better Value Option?
12:41pm, Monday, 16'th Jun 2025
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Dentsply International (XRAY) or Merit Medical (MMSI). But which of these two companies is the best o
ALGN vs. MMSI: Which Stock Should Value Investors Buy Now?
12:41pm, Tuesday, 27'th May 2025
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Align Technology (ALGN) and Merit Medical (MMSI). But which of these two stocks is more attractive to value
MMSI Stock Gains Following Latest Merger to Boost Hemostasis Portfolio
02:10pm, Wednesday, 21'st May 2025
Merit Medical aims to provide an additional effective solution that complements a wide range of percutaneous procedures, including interventional radiology and cardiology.
Merit Medical Acquires Biolife Delaware, L.L.C.
07:30am, Tuesday, 20'th May 2025
SOUTH JORDAN, Utah, May 20, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced that it has acquired Biolife Delaware, L.L.C.
Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis
09:25am, Tuesday, 06'th May 2025
SOUTH JORDAN, Utah, May 06, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that the Wrapsody Cell-Impermeable Endoprosth
LH vs. MMSI: Which Stock Is the Better Value Option?
12:46pm, Monday, 05'th May 2025
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Labcorp (LH) and Merit Medical (MMSI). But which of these two stocks offers value investors a better bang fo
In the AVG cohort of the US pivotal trial, the Merit WRAPSODY Cell-Impermeable Endoprosthesis (CIE) achieved 60.2% target lesion primary patency (TLPP) at 12 months. In the AVG cohort of the US pivota
